Quadrant Private Equity has sold Journey Beyond, an Australia-based experiential tourism business, to US-based Hornblower Group, which is best known for offering cruise and sightseeing packages.
Australia turnaround investor Allegro Funds has appointed Fay Bou as its third partner, serving alongside co-founders Adrian Loader and Chester Moynihan.
Pacific Equity Partners (PEP) has agreed on exits from two energy infrastructure-related businesses, taking the Australia-based private equity firm to four announced liquidity events within a fortnight.
Australia’s Blackbird Ventures has led a $25 million Series B round for Inventia Life Science, a local start-up that provides 3D cell cultures for research and clinical purposes.
Tiger Global Management has led a $325 million Series E round for Australia-based e-commerce marketing technology provider Rokt.
BGH Capital has submitted a take-private bid for Virtus Health, an Australia-based fertility care services provider, that values the business at approximately A$607.3 million ($432 million).
Software-as-a-service continues to benefit from a digitalization push across multiple markets. Investors are looking for differentiation in a market characterized by high valuations and intense competition
Pacific Equity Partners (PEP) has agreed two healthcare exits, with Australia-based medical devices distributor LifeHealthcare to be sold to Ebos Group and New Zealand corporate hospital platform Evolution Healthcare going to QIC and Sunsuper.
Ontario Teachers’ Pension Plan (OTPP) has made an investment of undisclosed size in KKR-backed GreenCollar, an environmental services provider that helped establish Australia’s carbon credit market.
Finder, an Australian financial technology start-up with a diversified suite of retail investor services, has raised A$30 million ($21.5 million) from local VC firm Future Now Capital.
Singapore-based Aura Private Equity has acquired a majority stake in Australian Vaccine Services (AVS), a leading provider of corporate flu vaccinations.
Sponsor-to-sponsor exits are set to reach a record high in Asia this year as private equity firms increase velocity of deployment and some strategics remain in a pandemic-induced funk
Goldman Sachs Asset Management has committed A$137 million ($96 million) to Synergis, an Australian investment platform focused on providing housing for people with disabilities.
Fortitude Investment Partners, an Australia-based private equity firm established by professionals from Blue Sky Alternative Investments, has backed cosmetic medical business Aura Medical Group.
Horizons Ventures, the private investment arm of Hong Kong billionaire Li Ka-Shing, has led a A$129 million ($92.3 million) Series B round for Australia’s Harrison.ai, a clinical artificial intelligence (AI) developer.
Airbus Ventures has led a $25 million Series B round for Australia’s Q-Ctrl, a quantum computing developer increasingly geared toward space tech and orbital infrastructure.
Tiger Global Management has led an A$89 million ($63.4 million) Series A round for Australian food-ordering start-up Mr Yum. In the past 12 months, 44% of Australians have used the platform.
Australia-based deal-by-deal investor Alceon Private Equity expects to complete four investments this year, having expanded its scope from consumer and retail to include healthcare, childcare, and IT services.
HESTA has acquired a A$120 million ($85 million) equity stake in Australian enterprise software and IT services provider Citadel, following its merger with medical practice software specialist Genie Solutions.
US private equity firms K1 Investment Management and Level Equity have invested about $350 million in Australia’s Simpro, a software-as-a-service (SaaS) provider focused on field service management.
Australia-based Five V Capital has sold a 25% GP stake to Pinnacle Investment Management Group, a listed multi-affiliate platform investor that has interests in 14 Australian asset managers.
EQT’s $1.67 billion acquisition of Icon Group underscores the recent trend in large-cap buyouts, as well as the long-term growth potential for cancer care specialists in Australia and the wider Asian region
Five V Capital, a growth-oriented investor in Australia and New Zealand, has achieved a first and final close on its fourth fund with more than A$550 million ($398 million) in commitments.
Goldman Sachs Asset Management, QIC, and Pagoda Investment – a China-focused GP set up by a former QIC executive – have agreed to sell Australia cancer care provider Icon Group to EQT for a reported valuation of A$2.3 billion ($1.67 billion).